Divestments

Aelin Therapeutics

Novel therapeutic modality to induce functional knockdown of a target protein

  • Sector
    Healthcare
  • Country
    Belgium
  • Fund
    LSP 5
  • Entry
    2017
  • Web
    aelintx.com
  • Exit
    2023
Aelin Therapeutics
0
Investments
EQT logo